Literature DB >> 19141764

Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial.

Mary M McDermott1, Philip Ades, Jack M Guralnik, Alan Dyer, Luigi Ferrucci, Kiang Liu, Miriam Nelson, Donald Lloyd-Jones, Linda Van Horn, Daniel Garside, Melina Kibbe, Kathryn Domanchuk, James H Stein, Yihua Liao, Huimin Tao, David Green, William H Pearce, Joseph R Schneider, David McPherson, Susan T Laing, Walter J McCarthy, Adhir Shroff, Michael H Criqui.   

Abstract

CONTEXT: Neither supervised treadmill exercise nor strength training for patients with peripheral arterial disease (PAD) without intermittent claudication have been established as beneficial.
OBJECTIVE: To determine whether supervised treadmill exercise or lower extremity resistance training improve functional performance of patients with PAD with or without claudication. DESIGN, SETTING, AND PARTICIPANTS: Randomized controlled clinical trial performed at an urban academic medical center between April 1, 2004, and August 8, 2008, involving 156 patients with PAD who were randomly assigned to supervised treadmill exercise, to lower extremity resistance training, or to a control group. MAIN OUTCOME MEASURES: Six-minute walk performance and the short physical performance battery. Secondary outcomes were brachial artery flow-mediated dilation, treadmill walking performance, the Walking Impairment Questionnaire, and the 36-Item Short Form Health Survey physical functioning (SF-36 PF) score.
RESULTS: For the 6-minute walk, those in the supervised treadmill exercise group increased their distance walked by 35.9 m (95% confidence interval [CI], 15.3-56.5 m; P < .001) compared with the control group, whereas those in the resistance training group increased their distance walked by 12.4 m (95% CI, -8.42 to 33.3 m; P = .24) compared with the control group. Neither exercise group improved its short physical performance battery scores. For brachial artery flow-mediated dilation, those in the treadmill group had a mean improvement of 1.53% (95% CI, 0.35%-2.70%; P = .02) compared with the control group. The treadmill group had greater increases in maximal treadmill walking time (3.44 minutes; 95% CI, 2.05-4.84 minutes; P < .001); walking impairment distance score (10.7; 95% CI, 1.56-19.9; P = .02); and SF-36 PF score (7.5; 95% CI, 0.00-15.0; P = .02) than the control group. The resistance training group had greater increases in maximal treadmill walking time (1.90 minutes; 95% CI, 0.49-3.31 minutes; P = .009); walking impairment scores for distance (6.92; 95% CI, 1.07-12.8; P = .02) and stair climbing (10.4; 95% CI, 0.00-20.8; P = .03); and SF-36 PF score (7.5; 95% CI, 0.0-15.0; P = .04) than the control group.
CONCLUSIONS: Supervised treadmill training improved 6-minute walk performance, treadmill walking performance, brachial artery flow-mediated dilation, and quality of life but did not improve the short physical performance battery scores of PAD participants with and without intermittent claudication. Lower extremity resistance training improved functional performance measured by treadmill walking, quality of life, and stair climbing ability. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00106327.

Entities:  

Mesh:

Year:  2009        PMID: 19141764      PMCID: PMC3268032          DOI: 10.1001/jama.2008.962

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  46 in total

Review 1.  The revised CONSORT statement for reporting randomized trials: explanation and elaboration.

Authors:  D G Altman; K F Schulz; D Moher; M Egger; F Davidoff; D Elbourne; P C Gøtzsche; T Lang
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

2.  Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery.

Authors:  J M Guralnik; L Ferrucci; C F Pieper; S G Leveille; K S Markides; G V Ostir; S Studenski; L F Berkman; R B Wallace
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2000-04       Impact factor: 6.053

3.  Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the women's health and aging study.

Authors:  M M McDermott; L Fried; E Simonsick; S Ling; J M Guralnik
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

4.  Measuring physical activity in peripheral arterial disease: a comparison of two physical activity questionnaires with an accelerometer.

Authors:  M M McDermott; K Liu; E O'Brien; J M Guralnik; M H Criqui; G J Martin; P Greenland
Journal:  Angiology       Date:  2000-02       Impact factor: 3.619

5.  Lower ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior tibial arterial pressures, and association with leg functioning in peripheral arterial disease.

Authors:  M M McDermott; M H Criqui; K Liu; J M Guralnik; P Greenland; G J Martin; W Pearce
Journal:  J Vasc Surg       Date:  2000-12       Impact factor: 4.268

6.  Gait alterations associated with walking impairment in people with peripheral arterial disease with and without intermittent claudication.

Authors:  M M McDermott; S M Ohlmiller; K Liu; J M Guralnik; G J Martin; W H Pearce; P Greenland
Journal:  J Am Geriatr Soc       Date:  2001-06       Impact factor: 5.562

7.  Resistance training in patients with peripheral arterial disease: effects on myosin isoforms, fiber type distribution, and capillary supply to skeletal muscle.

Authors:  M R McGuigan; R Bronks; R U Newton; M J Sharman; J C Graham; D V Cody; W J Kraemer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-07       Impact factor: 6.053

8.  Comparison of corridor and treadmill walking in patients with severe chronic obstructive pulmonary disease.

Authors:  P M Swerts; R Mostert; E F Wouters
Journal:  Phys Ther       Date:  1990-07

9.  Corridor-based functional performance measures correlate better with physical activity during daily life than treadmill measures in persons with peripheral arterial disease.

Authors:  Mary M McDermott; Philip A Ades; Alan Dyer; Jack M Guralnik; Melina Kibbe; Michael H Criqui
Journal:  J Vasc Surg       Date:  2008-10-01       Impact factor: 4.268

10.  Recruiting participants with peripheral arterial disease for clinical trials: experience from the Study to Improve Leg Circulation (SILC).

Authors:  Mary M McDermott; Kathryn Domanchuk; Alan Dyer; Philip Ades; Melina Kibbe; Michael H Criqui
Journal:  J Vasc Surg       Date:  2009-01-09       Impact factor: 4.860

View more
  128 in total

1.  Greater sedentary hours and slower walking speed outside the home predict faster declines in functioning and adverse calf muscle changes in peripheral arterial disease.

Authors:  Mary M McDermott; Kiang Liu; Luigi Ferrucci; Lu Tian; Jack M Guralnik; Yihua Liao; Michael H Criqui
Journal:  J Am Coll Cardiol       Date:  2011-06-07       Impact factor: 24.094

2.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

3.  Incidence and risk factors of peripheral arterial occlusive disease in a prospective cohort of 700 adult men followed for 5 years.

Authors:  Peter Henke
Journal:  World J Surg       Date:  2010-08       Impact factor: 3.352

Review 4.  Arterial prehabilitation: can exercise induce changes in artery size and function that decrease complications of catheterization?

Authors:  Amr Alkarmi; Dick H J Thijssen; Khalled Albouaini; N Timothy Cable; D Jay Wright; Daniel J Green; Ellen A Dawson
Journal:  Sports Med       Date:  2010-06-01       Impact factor: 11.136

5.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

Review 6.  Peripheral arterial disease and chronic heart failure: a dangerous mix.

Authors:  Sally C Inglis; Adriana Hermis; Sajad Shehab; Phillip J Newton; Sara Lal; Patricia M Davidson
Journal:  Heart Fail Rev       Date:  2013-07       Impact factor: 4.214

7.  Peripheral artery disease, calf skeletal muscle mitochondrial DNA copy number, and functional performance.

Authors:  Mary M McDermott; Charlotte A Peterson; Robert Sufit; Luigi Ferrucci; Jack M Guralnik; Melina R Kibbe; Tamar S Polonsky; Lu Tian; Michael H Criqui; Lihui Zhao; James H Stein; Lingyu Li; Christiaan Leeuwenburgh
Journal:  Vasc Med       Date:  2018-05-08       Impact factor: 3.239

8.  Effect of Resveratrol on Walking Performance in Older People With Peripheral Artery Disease: The RESTORE Randomized Clinical Trial.

Authors:  Mary M McDermott; Christiaan Leeuwenburgh; Jack M Guralnik; Lu Tian; Robert Sufit; Lihui Zhao; Michael H Criqui; Melina R Kibbe; James H Stein; Donald Lloyd-Jones; Stephen D Anton; Tamar S Polonsky; Ying Gao; Rafael de Cabo; Luigi Ferrucci
Journal:  JAMA Cardiol       Date:  2017-08-01       Impact factor: 14.676

Review 9.  Functional impairment in peripheral artery disease and how to improve it in 2013.

Authors:  Mary McGrae McDermott
Journal:  Curr Cardiol Rep       Date:  2013-04       Impact factor: 2.931

Review 10.  The effect of exercise on fitness and performance-based tests of function in intermittent claudication: a systematic review.

Authors:  Belinda J Parmenter; Jacqueline Raymond; Maria A Fiatarone Singh
Journal:  Sports Med       Date:  2013-06       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.